KP

Karinza Phoenix

Chief Executive Officer & Managing Director

Myopharm Limited

Melbourne, Victoria


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Myopharm Limited
Industry
biotechnology
Employees
4.0
Seniority
C suite
Annual Revenue
1400000.0

Technologies

Route 53 Gmail Google Apps Squarespace ECommerce Mobile Friendly YouTube Shutterstock AI

Keywords

biotechnology therapeutics orphan rare diseases metabolic diseases diabetes metabolic syndromes t2d r d type 2 diabetes prediabetes insulin resistance ind approved betacellcentric weightloss endocrinology beta-cell function combination drug diabetes therapeutics medical foods weight loss product pge2 signaling pathway clinical pipeline novel therapeutics treatment failures pro-inflammatory mediators dual combination drug healthcare innovation chronic study acute study research collaboration diabetes management clinical validation clinical care diabetes congress health at every size investing in biotech global prevalence of diabetes patient education nutritional intervention healthcare professionals food standards compliance personalized treatment evidence-based practice diabetes services scheme dietitian consultation blood sugar management prevention strategies biotechnology company investor relations healthcare partnerships medical research disease prevention participant recruitment patient support medical compliance therapeutic strategy clinical studies healthcare analytics risk assessment medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans